Serum Institute of India (SII) gets nod of DGCI to start the final phase of human trials for Covishield vaccine from next week. The Oxford-AstraZeneca's vaccine candidate is being manufactured in India by SII. Meanwhile, Railway has decided to allow 500 suburban trains in Mumbai instead of 350 after 10% employees of co-operative and private banks to travel via locals. Also, Railway Minister Piyush Goyal Watch the full video for more updates on the pandemic.